|University of Vienna||Head of Technology Transfer||Austria|
What to ensure before the creation of a viable spinout opportunity?
Dr. Jürgen Walkenhorst studied biology/molecular biology in Osnabrück and Aberdeen (UK). After his diploma thesis at the EMBL in Heidelberg, he worked at Genentech, Inc. (USA). He undertook his PhD-thesis at the Max-Planck-Institute for Developmental Biology in Tübingen. He joined Cellzome AG (Heidelberg, now part of GSK) as the first employee where he was instrumental in setting up the company and was later responsible for IP-issues. After a stint in the patent department of Baxter AG in Vienna, he changed to technology transfer. At Austria Wirtschaftsservice GmbH, Vienna, he was managing life science inventions developed at Austrian universities.
In 2007 he moved to PROvendis, the central technology transfer agency of the universities of North Rhine-Westphalia, where he served as the head of the Life sciences team. Moving back to Austria in 2019, he is currently the head of technology transfer at the University of Vienna, the largest and oldest university in the present German-speaking world. He also holds a Masters degree in Pharmaceutical Business Development and Licensing from the University of Manchester.